CLINICAL_TRIALS
trial_result
· 2015-10-14
Clinical Trial Update: Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection [Phase 4]
Summary
A Phase 4 clinical trial update evaluating a short-course, high-dose primaquine regimen for liver-stage Plasmodium vivax malaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Papua New Guinea Institute of Medical Research | Conditions: Plasmodium Vivax | Phase 4 | Status: UNKNOWN